Simplex Trading’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.2K | Buy |
+22,671
| New | +$56.3K | ﹤0.01% | 5898 |
|
|
2025
Q4 | – | Sell |
-2,942
| Closed | -$6K | – | 9732 |
|
|
2025
Q3 | $6K | Buy |
+2,942
| New | +$4.79K | ﹤0.01% | 8220 |
|
|
2024
Q4 | – | Sell |
-3,414
| Closed | -$4.83K | – | 9374 |
|
|
2024
Q3 | $3K | Buy |
3,414
+3,347
| +4,996% | +$3.52K | ﹤0.01% | 7874 |
|
|
2024
Q2 | $0 | Sell |
67
-392
| -85% | -$463 | ﹤0.01% | 9579 |
|
|
2024
Q1 | $0 | Buy |
+459
| New | +$685 | ﹤0.01% | 9639 |
|
|
2023
Q4 | – | Sell |
-4,813
| Closed | -$7.49K | – | 9576 |
|
|
2023
Q3 | $7K | Sell |
4,813
-61,566
| -93% | -$111K | ﹤0.01% | 7449 |
|
|
2023
Q2 | $132K | Buy |
+66,379
| New | +$158K | ﹤0.01% | 4753 |
|
|
2021
Q4 | – | Sell |
-69,049
| Closed | -$72.3K | – | 11215 |
|
|
2021
Q3 | $129K | Hold |
69,049
| – | – | ﹤0.01% | 6261 |
|
|
2021
Q2 | $131K | Buy |
69,049
+24,801
| +56% | +$85.4K | ﹤0.01% | 6350 |
|
|
2021
Q1 | $197K | Buy |
+44,248
| New | +$206K | ﹤0.01% | 4763 |
|
|
2020
Q4 | – | Sell |
-18,043
| Closed | -$64.7K | – | 8898 |
|
|
2020
Q3 | $69K | Buy |
18,043
+15,846
| +721% | +$57.3K | ﹤0.01% | 5297 |
|
|
2020
Q2 | $8K | Buy |
+2,197
| New | +$7.51K | ﹤0.01% | 6765 |
|
|
2019
Q2 | – | Sell |
-2,030
| Closed | -$8K | – | 7617 |
|
|
2019
Q1 | $8K | Sell |
2,030
-50
| -2% | -$225 | ﹤0.01% | 6280 |
|
|
2018
Q4 | $6K | Buy |
2,080
+1,855
| +824% | +$8.81K | ﹤0.01% | 6146 |
|
|
2018
Q3 | $1K | Buy |
225
+175
| +350% | +$878 | ﹤0.01% | 7216 |
|
|
2018
Q2 | $0 | Sell |
50
-1,860
| -97% | -$8.27K | ﹤0.01% | 7773 |
|
|
2018
Q1 | $10K | Buy |
1,910
+830
| +77% | +$5.46K | ﹤0.01% | 4043 |
|
|
2017
Q4 | $7K | Sell |
1,080
-670
| -38% | -$4.52K | ﹤0.01% | 4215 |
|
|
2017
Q3 | $10K | Sell |
1,750
-50
| -3% | -$320 | ﹤0.01% | 3777 |
|
|
2017
Q2 | $15K | Sell |
1,800
-11,044
| -86% | -$104K | ﹤0.01% | 3587 |
|
|
2017
Q1 | $174K | Buy |
+12,844
| New | +$115K | 0.01% | 1316 |
|
|
2016
Q4 | – | Sell |
-561
| Closed | -$3K | – | 6367 |
|
|
2016
Q3 | $3K | Buy |
+561
| New | +$3.5K | ﹤0.01% | 4724 |
|
|
2016
Q2 | – | Sell |
-13
| Closed | -$104 | – | 6321 |
|
|
2016
Q1 | $0 | Buy |
+13
| New | +$111 | ﹤0.01% | 6088 |
|
|
2015
Q3 | – | Sell |
-785
| Closed | -$12.5K | – | 6039 |
|
|
2015
Q2 | $15K | Sell |
785
-1,605
| -67% | -$33.3K | ﹤0.01% | 2722 |
|
|
2015
Q1 | $42K | Buy |
2,390
+2,255
| +1,670% | +$44.1K | ﹤0.01% | 1702 |
|
|
2014
Q4 | $2K | Buy |
+135
| New | +$2.9K | ﹤0.01% | 3799 |
|
Other funds holding PLX
MCO
SWP
VPM
PFS
OM
Simplex Trading's PLX Position: Q1 2026 in Review
Simplex Trading opened a new position in Protalix BioTherapeutics (PLX) in Q1 2026: 22,671 shares worth $49.2K. The stake represents ﹤0.01% of the portfolio and ranks #5898 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PLX as recently as Q3 2025.
Simplex Trading first reported a position in PLX in Q4 2014 and has held it in 26 quarters since. The position peaked at $197K in Q1 2021. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.
- Simplex Trading held 22,671 shares of Protalix BioTherapeutics worth $49.2K as of Q1 2026.
- Protalix BioTherapeutics was a new Simplex Trading position in Q1 2026.
- Protalix BioTherapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5898 holding.
- Simplex Trading first reported a position in Protalix BioTherapeutics in Q4 2014 and has held it in 26 quarters since.
- Simplex Trading's Protalix BioTherapeutics position peaked at $197K in Q1 2021.
- 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.